10x Genomics, Inc. Stock

10xgenomics.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $222.59MM

10x Genomics is a biotechnology company offering a range of products including software and hardware all aimed at better understanding biological systems.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to 10x Genomics, Inc. before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like 10x Genomics, Inc. before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

10x Genomics, Inc.’s stock FAQs


Can you buy 10x Genomics, Inc.’s stock?

You can no longer buy 10x Genomics, Inc.’s stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

Can you sell 10x Genomics, Inc.’s stock?

You can no longer sell stock of 10x Genomics, Inc. on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

What is 10x Genomics, Inc.’s stock price?

The stock price of 10x Genomics, Inc. is $42.01 as of 1/18/24.

What is 10x Genomics, Inc.’s stock ticker symbol?

The ticker symbol of 10x Genomics, Inc. is TXG.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.


Management Team

Serge Saxonov
Chief Executive Officer, Co-founder
Brad Crutchfield
Chief Commercial Officer
Ben Hindson
Chief Scientific Officer, President, Co-founder
Justin McAnear
Chief Financial Officer
Jean Philibert
Chief People Officer
Sam Ropp
Senior Vice President, Global Sales
Jonathan Schimmel
Vice President, Global Support and Sales Operations
Michael Schnall-Levin
Senior Vice President, R&D, Founding Scientist
Alexander Wong
Senior Vice President, Product, Software & Infrastructure
Paul Wyatt
Vice President, Operations
Eric Whitaker
General Counsel

Board Members

Serge Saxonov
Shehnaaz Suliman, M.D., M.Phil., M.B.A.
Sri Kosaraju
Mathai Mammen
Bryan Roberts, Ph.D.
John Stuelpnagel
Ben Hindson


10x Genomics Prices Initial Public Offering | FinSMEs

10x Genomics, a Pleasonton, Calif.-based company that build products combining hardware, chemistry, and software to give single cell and spatial views of biological systems, priced its initial public offering
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.